BlackThorn Therapeutics Garners $40,000,000 Series A Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7cee3d7c-5f48-4100-bb21-1f7e9b01e8e2
Date
10/21/2016
Company Name
BlackThorn Therapeutics
Mailing Address
329 Oyster Point Blvd 3rd Floor South San Francisco, CA 94080 USA
Company Description
BlackThorn Therapeutics is a clinical-stage biopharmaceutical company dedicated to transforming the lives of people with neurobehavioral disorders through the discovery and development of novel, targeted treatments.
Website
http://www.blackthornrx.com
Transaction Type
Venture Equity
Transaction Amount
$40,000,000
Transaction Round
Series A
Proceeds Purposes
Proceeds purposes were not disclosed.
M&A Terms
Venture Investor
ARCH Venture Partners
Venture Investor
Johnson & Johnson Development Corporation
Venture Investor
Altitude Life Science Ventures
Venture Investor
Mercury Fund
Venture Investor
Alexandria Venture Investments
Venture Investor
Undisclosed